Noninvasive Hemoglobin Monitoring System Performs Accurately During Hemorrhage

Hemoglobin (Hb) measurements obtained by a noninvasive Hb measurement system, showed accurate performance during hemorrhage conditions compared with invasive point-of-care (POC) devices.

Noninvasive measurement of Hb has many advantages including the prevention of pain and potential transmission of infectious diseases, the reduced need for trained personnel, and the freedom to take multiple measurements continuously. The monitoring system, called NBM 200MP, offers a unique, noninvasive solution for accurate and quick Hb measurements.

OrSense (Nes Ziona, Israel), a company which develops monitors for noninvasive measurements of various blood parameters, reported that NBM 200MP, a noninvasive Hb measurement system, showed accurate performance during hemorrhage conditions compared with invasive point-of-care (POC) devices. The report was presented as an oral presentation at the American Society of Anesthesiologists (ASA) annual meeting in San Diego (CA, USA), which took place from October 16-20, 2010.

Current measurement methods of Hb are invasive, painful, time consuming, and labor intensive, and inadequate for continuous Hb monitoring. Noninvasive measurement of Hb has many advantages including the prevention of pain and potential transmission of infectious diseases, the reduced need for trained personnel, and the freedom to take multiple measurements continuously.

At the same ASA conference, another study validated the performance of NBM 200MP for continual, safe and reliable monitoring of oxygen saturation levels, even in extreme cases of low perfusion and weak pulsation, when standard pulse oximeters fail. Thus, the NBM 200MP occlusion-based oximetry may overcome the limitations of pulse oximetry, and improve the ability to detect hypoxemia and related events. The NBM 200MP oximetry monitor is [U.S.] Food and Drug Administration (FDA; Silver Spring, MD, USA) cleared.

Related Links:
OrSense
[U.S.] Food and Drug Administration